Gregory Gordon

1.2k total citations
6 papers, 230 citations indexed

About

Gregory Gordon is a scholar working on Molecular Biology, Genetics and Immunology. According to data from OpenAlex, Gregory Gordon has authored 6 papers receiving a total of 230 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Molecular Biology, 2 papers in Genetics and 2 papers in Immunology. Recurrent topics in Gregory Gordon's work include Genetic Syndromes and Imprinting (2 papers), Hedgehog Signaling Pathway Studies (2 papers) and Genetic and Kidney Cyst Diseases (2 papers). Gregory Gordon is often cited by papers focused on Genetic Syndromes and Imprinting (2 papers), Hedgehog Signaling Pathway Studies (2 papers) and Genetic and Kidney Cyst Diseases (2 papers). Gregory Gordon collaborates with scholars based in United States, Netherlands and Germany. Gregory Gordon's co-authors include Guojun Yuan, Robert Haws, Jack A. Yanovski, Murray Stewart, Sheila M. Brady, Vojo Vukovic, Robert N. Raju, Lee S. Rosen, Robert Bradley and Michael D. Karol and has published in prestigious journals such as BMC Cancer, Diabetes Obesity and Metabolism and Journal of the Endocrine Society.

In The Last Decade

Gregory Gordon

6 papers receiving 227 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gregory Gordon United States 5 117 54 53 32 32 6 230
Jesús M. López Martí Spain 9 107 0.9× 41 0.8× 41 0.8× 17 0.5× 69 2.2× 15 353
V. Ayinampudi United Kingdom 6 130 1.1× 50 0.9× 135 2.5× 8 0.3× 59 1.8× 7 289
Analía Gabriela Ricci Argentina 11 40 0.3× 66 1.2× 38 0.7× 18 0.6× 22 0.7× 18 445
Ananya De United States 8 136 1.2× 14 0.3× 61 1.2× 7 0.2× 80 2.5× 15 292
Nathalie Chami United States 6 86 0.7× 71 1.3× 21 0.4× 6 0.2× 42 1.3× 7 202
Hamzeh Rezaei Iran 11 183 1.6× 45 0.8× 10 0.2× 14 0.4× 36 1.1× 19 320
Virginie Vauthier France 11 112 1.0× 38 0.7× 142 2.7× 6 0.2× 62 1.9× 17 345
John J. Osborne United States 10 104 0.9× 50 0.9× 10 0.2× 30 0.9× 40 1.3× 12 232
Yingying Bao China 9 88 0.8× 11 0.2× 58 1.1× 11 0.3× 28 0.9× 31 336
Hiroshi Ogihara Japan 3 79 0.7× 41 0.8× 22 0.4× 14 0.4× 29 0.9× 7 326

Countries citing papers authored by Gregory Gordon

Since Specialization
Citations

This map shows the geographic impact of Gregory Gordon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gregory Gordon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gregory Gordon more than expected).

Fields of papers citing papers by Gregory Gordon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gregory Gordon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gregory Gordon. The network helps show where Gregory Gordon may publish in the future.

Co-authorship network of co-authors of Gregory Gordon

This figure shows the co-authorship network connecting the top 25 collaborators of Gregory Gordon. A scholar is included among the top collaborators of Gregory Gordon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gregory Gordon. Gregory Gordon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

6 of 6 papers shown
1.
2.
Haws, Robert, Gregory Gordon, Joan C. Han, et al.. (2021). The efficacy and safety of setmelanotide in individuals with Bardet-Biedl syndrome or Alström syndrome: Phase 3 trial design. Contemporary Clinical Trials Communications. 22. 100780–100780. 31 indexed citations
3.
Clément, Karine, Erica L T van den Akker, Gregory Gordon, Guojun Yuan, & Peter Kühnen. (2021). Timing of Onset of Adverse Events With Setmelanotide, an MC4R Agonist, in Patients With Severe Obesity Due to LEPR or POMC Deficiency. Journal of the Endocrine Society. 5(Supplement_1). A30–A31. 3 indexed citations
4.
Clément, Karine, Jesús Argente, Allison Bahm, et al.. (2021). Efficacy and safety of setmelanotide, an MC4R agonist, in individuals with severe obesity due to LEPR or POMC deficiency: single-arm, open-label, multicentre, phase 3 trials. Yearbook of pediatric endocrinology. 5 indexed citations
5.
Haws, Robert, Sheila M. Brady, Guojun Yuan, et al.. (2020). Effect of setmelanotide, a melanocortin‐4 receptor agonist, on obesity in Bardet‐Biedl syndrome. Diabetes Obesity and Metabolism. 22(11). 2133–2140. 97 indexed citations
6.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jesús M. López Martí Breakdown of academic impact, for papers by V. Ayinampudi Breakdown of academic impact, for papers by Analía Gabriela Ricci Breakdown of academic impact, for papers by Ananya De Breakdown of academic impact, for papers by Nathalie Chami Breakdown of academic impact, for papers by Hamzeh Rezaei Breakdown of academic impact, for papers by Virginie Vauthier Breakdown of academic impact, for papers by John J. Osborne Breakdown of academic impact, for papers by Yingying Bao Breakdown of academic impact, for papers by Hiroshi Ogihara
Rankless by CCL
2026